Charles River Laboratories

• Do You Own This $2 Billion Hedge Fund’s Best Stock Picks?

  By Meena Krishnamsetty - February 1, 2013 | Tickers: AGO, CAR, CRL, IRWD, TRIP

  Smaller cap stocks don't get as much attention from bankers, analysts, and most other investors. Generally speaking, this leaves them less-efficiently priced than their larger peers. Hedge funds take advantage of this by dedicating their research teams to work on the little guys, and consequently, they produce a significant amount of their alpha from the small-caps. According to our analysis, investing in the smart money’s top small-cap picks more »

• Billion Dollar Manager David Dreman’s Biggest Holdings

  By Meena Krishnamsetty - January 22, 2013 | Tickers: ASBC, CRL, CDE, FWLT, HBI

  David Dreman has been the head of Dreman Value Management since 1977, opening the doors to his own investment firm after working as director of research and senior investment officer for a number of years previously. He is also a noted writer, contributing to Forbes Magazine and various behavioral finance publications. He currently manages $4 billion in assets, down from $22 billion in 2007, where he was faced with loss more »

• Why Are Insiders Selling These Two Stocks?

  By Meena Krishnamsetty - July 12, 2012 | Tickers: CRL, EW

  Many years of experience working directly with insiders has taught that there can be countless reasons an insider will sell shares of his company’s stock. When we keep track of insiders selling shares of their own stock, taking the time to look for those reasons instead of jumping to conclusions can help avoid bad decisions based on assumptions.

  Contrary to popular belief, officers and directors of public companies are more »